VSM Wealth Advisory’s Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock CYCCP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$26.4K	Buy	4,802 +2,025	+73%	+$11.1K	0.01%	277
2025 Q1	$13K	Buy	+2,777	New	+$13K	﹤0.01%	322